Cargando…

Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097

Detalles Bibliográficos
Autores principales:	Jeay, Sébastien, Gaulis, Swann, Ferretti, Stéphane, Bitter, Hans, Ito, Moriko, Valat, Thérèse, Murakami, Masato, Ruetz, Stephan, Guthy, Daniel A, Rynn, Caroline, Jensen, Michael R, Wiesmann, Marion, Kallen, Joerg, Furet, Pascal, Gessier, François, Holzer, Philipp, Masuya, Keiichi, Würthner, Jens, Halilovic, Ensar, Hofmann, Francesco, Sellers, William R, Graus Porta, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2016
Materias:	Human Biology and Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114012/ https://www.ncbi.nlm.nih.gov/pubmed/27852439 http://dx.doi.org/10.7554/eLife.19317

Ejemplares similares

A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
por: Jeay, Sébastien, et al.
Publicado: (2015)

Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
por: Bauer, Sebastian, et al.
Publicado: (2021)

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance
por: Zhang, Meng, et al.
Publicado: (2020)

5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2()
por: Dickens, Michael P., et al.
Publicado: (2013)

The Expression and Function of NUMB in Endometrial Cancer and the Interaction with HDM2 and P53
por: Wang, Chao, et al.
Publicado: (2015)

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
por: Stein, Eytan M., et al.
Publicado: (2022)

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
por: Carita, Guillaume, et al.
Publicado: (2016)

The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2020)

Oligobenzamide proteomimetic inhibitors of the p53–hDM2 protein–protein interaction
por: Plante, Jeffrey P., et al.
Publicado: (2009)

Effect of linker on the binding free energy of stapled p53/HDM2 complex
por: Im, Haeri, et al.
Publicado: (2020)

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
por: Fischer, Peter M.
Publicado: (2006)

Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26
por: Zhang, Ying, et al.
Publicado: (2010)

Activity‐Directed Synthesis of Inhibitors of the p53/hDM2 Protein–Protein Interaction
por: Green, Adam I., et al.
Publicado: (2020)

Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53
por: Heminger, Katherine, et al.
Publicado: (2009)

Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress
por: Bai, Dongmei, et al.
Publicado: (2014)

Helicobacter pylori bacteria alter the p53 stress response via Erk-HDM2 pathway
por: Bhardwaj, Vikas, et al.
Publicado: (2015)

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
por: Jung, Joonil, et al.
Publicado: (2016)

Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
por: Liu, Li-Juan, et al.
Publicado: (2016)

NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulation
por: Ruan, Banjun, et al.
Publicado: (2020)

MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
por: Seipel, Katja, et al.
Publicado: (2018)

A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism
por: Bond, GL, et al.
Publicado: (2005)

Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression
por: Wang, J, et al.
Publicado: (2016)

Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma
por: Kalmodia, Sushma, et al.
Publicado: (2017)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

O097: Abstract withdrawn
Publicado: (2013)

p14(ARF )expression in invasive breast cancers and ductal carcinoma in situ – relationships to p53 and Hdm2
por: Vestey, SB, et al.
Publicado: (2004)

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes
por: Kashuba, Elena, et al.
Publicado: (2003)

Mechanistic Validation of a Clinical Lead Stapled Peptide that Reactivates p53 by Dual HDM2 and HDMX Targeting
por: Wachter, Franziska, et al.
Publicado: (2016)

HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
por: Sosin, Angela M, et al.
Publicado: (2012)

Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome
por: Chan, Ying, et al.
Publicado: (2016)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

The p53 Tumor Suppressor-Like Protein nvp63 Mediates Selective Germ Cell Death in the Sea Anemone Nematostella vectensis
por: Pankow, Sandra, et al.
Publicado: (2007)

Clinorotation-induced autophagy via HDM2-p53-mTOR pathway enhances cell migration in vascular endothelial cells
por: Li, Cheng-Fei, et al.
Publicado: (2018)

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells
por: Wu, Chiao-En, et al.
Publicado: (2021)

The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
por: Martiny-Baron, Georg, et al.
Publicado: (2010)

PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis
por: Sarafraz-Yazdi, Ehsan, et al.
Publicado: (2022)

Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells
por: Ding, Li, et al.
Publicado: (2021)

Modeling of Arylamide Helix Mimetics in the p53 Peptide Binding Site of hDM2 Suggests Parallel and Anti-Parallel Conformations Are Both Stable
por: Fuller, Jonathan C., et al.
Publicado: (2012)

AB097. Treatment of long segment stenosis of ureter
por: Li, Sheng-Wen, et al.
Publicado: (2015)

TCTAP C-097 Coronary Perforation With a Twist
por: Loh, Hoong Sheng
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d9gec649em1cgi4e5jmvfv2tl3